Accessibility to air travel correlates strongly with increasing melanoma incidence.

Abstract:

:As the cost of air travel has decreased substantially in the USA and Europe over the past few decades, leisure travel to vacation destinations during the winter months has expanded significantly. This trend has probably increased the incidence of significant ultraviolet radiation exposure and sunburn in a broader population who could not previously afford this kind of travel. The purpose of this study was to analyse the correlation between increasing accessibility to air travel and melanoma incidence. This ecological study surveyed air travel patterns and melanoma incidence over the past three decades. Melanoma age-adjusted incidence was obtained from the United States Surveillance, Epidemiology, and End Results 9 Registry Database, 1975-2000, and the Cancer Registry of Norway, 1965-2000. United States mean inflation-adjusted airfare prices for four airports linked to leisure destinations (Miami, Los Angeles, San Diego, Phoenix) were compared with melanoma incidence. Parallel analyses were performed using annual domestic passenger-kilometres and melanoma incidence in Norway. Declining United States leisure-specific airfares corresponded strongly with increasing melanoma incidence (r = 0.96, r = 0.92, P < 0.001). Modelling a 5-year time lag between airfare and melanoma diagnosis strengthened the association (r = 0.98, r = 0.96, P < 0.001). Longer time lags could not be modelled due to data limitations. Data from Norway similarly showed that increasing air passenger mileage corresponded strongly with increasing melanoma incidence. Although correlation does not equate to causality, the very strong relationship between increasing access to air travel and melanoma incidence suggests that changes in recreational patterns may be contributing significantly to the public health problem of melanoma.

journal_name

Melanoma Res

journal_title

Melanoma research

authors

Agredano YZ,Chan JL,Kimball RC,Kimball AB

doi

10.1097/01.cmr.0000195696.50390.23

subject

Has Abstract

pub_date

2006-02-01 00:00:00

pages

77-81

issue

1

eissn

0960-8931

issn

1473-5636

pii

00008390-200602000-00012

journal_volume

16

pub_type

杂志文章
  • Regulation of interleukin-8 mRNA expression and protein secretion in a melanoma cell line by tumour necrosis factor-alpha and interferon-gamma.

    abstract::Interleukin-8 (IL-8) is a cytokine that is thought to promote melanoma tumour progression. We evaluated and adapted a non-radioactive, reverse transcriptase-polymerase chain reaction method for semiquantitative analysis of IL-8 mRNA expression. Using this technique we studied the regulation of IL-8 levels in the melan...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199608000-00005

    authors: Möhler T,Scheibenbogen C,Häfele J,Willhauck M,Keilholz U

    更新日期:1996-08-01 00:00:00

  • MDM2 SNP309 promoter polymorphism confers risk for hereditary melanoma.

    abstract::The p53 pathway regulates stress response, and variations in p53, MDM2, and MDM4 may predispose an individual to tumor development. The aim of this study was to study the impact of genetic variation on sporadic and hereditary melanoma. We have analyzed a combination of three functionally relevant variants of the p53 p...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000063

    authors: Thunell LK,Bivik C,Wäster P,Fredrikson M,Stjernström A,Synnerstad I,Rosdahl I,Enerbäck C

    更新日期:2014-06-01 00:00:00

  • Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases.

    abstract::The aim of our study was to evaluate the clinical and morphological features of primary malignant melanomas of the urinary bladder. We obtained information on five such cases from three different institutions. These were three men and two women between 52 and 76 years of age. Three tumors presented with hematuria, one...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000300

    authors: Karabulut YY,Erdogan S,Sayar H,Ergen A,Ertoy Baydar D

    更新日期:2016-12-01 00:00:00

  • Superficial spreading melanoma: an analysis of 97 702 cases using the SEER database.

    abstract::Superficial spreading melanoma (SSM) is the most common type of melanoma. Large, population-based studies analyzing the incidence and survival of SSM are limited. This retrospective study was designed to evaluate demographic factors influencing the incidence and survival of SSM using a national population-based databa...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000245

    authors: Singh P,Kim HJ,Schwartz RA

    更新日期:2016-08-01 00:00:00

  • Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.

    abstract::The aim was to evaluate toxicity and oncological outcome of combined stereotactic radiosurgery (SRS) and immunotherapy or targeted therapy in patients with multiple brain metastases originating from malignant melanoma. Despite the fact that both SRS and kinase inhibitors or immune checkpoint inhibitors are considered ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000542

    authors: Stera S,Balermpas P,Blanck O,Wolff R,Wurster S,Baumann R,Szücs M,Loutfi-Krauss B,Wilhelm ML,Seifert V,Rades D,Rödel C,Dunst J,Hildebrandt G,Arnold A,Meissner M,Kähler KC

    更新日期:2019-04-01 00:00:00

  • Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.

    abstract::The retinoblastoma protein (pRb) pathway is critical in regulating the G1 phase of the cell cycle and it is frequently disrupted in human cancers. Components of the pRb pathway which are often altered in tumour progression include the INK4 cyclin-dependent kinase (CDK) inhibitors p16INK4a/ CDKN2A and p15INK4b/CDKN2B, ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199902000-00003

    authors: Rizos H,Darmanian AP,Indsto JO,Shannon JA,Kefford RF,Mann GJ

    更新日期:1999-02-01 00:00:00

  • The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.

    abstract::Recently, TROG 02.01 results showed that in stage III melanoma patients with nodal metastasis, adjuvant radiation to lymph node basin after nodal dissection improves lymph node field relapse without an overall survival (OS) benefit. However, this trial was neither designed nor powered to detect an OS difference. In th...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000292

    authors: Danish HH,Patel KR,Switchenko JM,Gillespie TW,Jhaveri J,Chowdhary M,Abugideiri M,Delman KA,Lawson DH,Khan MK

    更新日期:2016-12-01 00:00:00

  • Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.

    abstract::Anecdotal cases of partial or complete responses have been reported after ipilimumab therapy for stage IV melanoma with brain metastasis treated earlier by surgery or radiosurgery. We report the first case of ipilimumab monotherapy resulting in durable complete remission of untreated, progressive brain metastases in a...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e3283364a37

    authors: Schartz NE,Farges C,Madelaine I,Bruzzoni H,Calvo F,Hoos A,Lebbé C

    更新日期:2010-06-01 00:00:00

  • Serum melatonin levels in melanoma patients after repeated oral administration.

    abstract::The goal of this study was to determine the effect of oral melatonin in divided doses on plasma melatonin levels in patients with metastatic melanoma. Hourly blood samples were obtained from five patients for 24 h prior to melatonin administration and for 24 h during oral administration of melatonin, 50 mg every 4 h. ...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-199402000-00009

    authors: Kane MA,Johnson A,Nash AE,Boose D,Mathai G,Balmer C,Yohn JJ,Robinson WA

    更新日期:1994-02-01 00:00:00

  • Synchronous high-risk melanoma and lymphoid neoplasia.

    abstract::Large population-based studies have shown a significant association between melanoma and lymphoid neoplasia, particularly non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL), that is independent of any treatment received for the initial tumour. This study examines the presentation, diagnosis, treatmen...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200110000-00012

    authors: Cahill RA,McGreal G,Neary P,Redmond HP

    更新日期:2001-10-01 00:00:00

  • 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.

    abstract::The aim of this study was to evaluate metastatic latency and survival after the occurrence of metastases in patients with choroidal/ciliary body melanoma treated with proton therapy. This was a retrospective cohort study. All consecutive patients with choroidal/ciliary body melanoma treated with proton therapy between...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000519

    authors: Bellocq D,Roy P,Kodjikian L,Mathis T,Nguyen AM,Herault J,Rivoire M,Négrier S,Thariat J,Grange JD

    更新日期:2020-06-01 00:00:00

  • 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.

    abstract::Staging of melanoma patients by means of whole body functional imaging in a single evaluation session using positron emission tomography (PET) with fluorine-18- labelled deoxy-d-glucose (FDG) as a metabolic tracer has created much interest over the last decade. After enthusiastic pilot studies, more attention has been...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200209000-00010

    authors: Stas M,Stroobants S,Dupont P,Gysen M,Hoe LV,Garmyn M,Mortelmans L,Wever ID

    更新日期:2002-10-01 00:00:00

  • Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma.

    abstract::The aim of the study was to identify the frequency of asymptomatic brain metastases detected by computed tomography (CT) scans in patients with metastatic cutaneous melanoma referred to first-line systemic treatment. Between 1995 and 2009, 697 Danish patients were screened with a contrast-enhanced CT scan of the brain...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e32835ae915

    authors: Zukauskaite R,Schmidt H,Asmussen JT,Hansen O,Bastholt L

    更新日期:2013-02-01 00:00:00

  • Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.

    abstract::The objective of this study was to describe the risk factor profile of skin cancer screening participants and to determine whether there is an association between the number of skin cancer/melanoma risk factors and the likelihood of diagnosis of a malignant melanoma. Seventy skin cancer screening clinics were held by ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/01.cmr.0000205023.02527.ab

    authors: Williams HA,Fritschi L,Beauchamp C,Katris P

    更新日期:2006-08-01 00:00:00

  • The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.

    abstract::We have observed that an early increase in the CD4+/CD8+ ratio of metastatic melanoma patients during chemoimmunotherapy is the most favourable independent prognostic factor. In this study, 87 patients with metastatic melanoma were monitored for peripheral blood lymphocyte subsets (CD4+ and CD8+) before and during che...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200412000-00009

    authors: Hernberg MM,Hahka-Kemppinen MH,Pyrhönen SO

    更新日期:2004-12-01 00:00:00

  • Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastases.

    abstract::Downstream of Ras, the serine/threonine kinase B-raf has been reported to be mutated, amongst other carcinomas, in a substantial subset of primary melanomas, with a preponderance of mutations within the kinase domain, including the activating V599E and V599K transitions. We investigated a representative series of 54 r...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200510000-00011

    authors: Kirschner M,Helmke B,Starz H,Benner A,Thome M,Deichmann M

    更新日期:2005-10-01 00:00:00

  • Update: current management issues in malignant melanoma.

    abstract::The incidence of melanoma has increased continuously during the last decade. Surgery is the mainstay of therapy but, for patients with thick lesions or regional metastatic lymph nodes, there is a high risk of relapse. For this group of patients, there is no standard therapy or general agreement amongst oncologists. In...

    journal_title:Melanoma research

    pub_type: 杂志文章,评审

    doi:10.1097/00008390-200510000-00001

    authors: Queirolo P,Acquati M,Kirkwood JM,Eggermont AM,Rocca A,Testori A

    更新日期:2005-10-01 00:00:00

  • The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor.

    abstract::Treatment of patients with metastatic uveal melanoma is very challenging because the tumor commonly spreads to the liver, surgical resection of metastases is rarely possible, and there is no standard effective systemic therapy. We report the case of a 38-year-old man, who presented with metastatic involvement of the l...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328344958c

    authors: Kolandjian NA,Patel SP,Papadopoulos NE,Bedikian AY

    更新日期:2011-04-01 00:00:00

  • A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.

    abstract::We studied the efficacy, tolerability and clinical courses of dabrafenib in patients with metastatic melanoma who were ineligible for enrolment into a clinical trial. Between July 2011 and May 2013, patients with unresectable stage III or stage IV, V600-mutated metastatic melanoma who were not eligible for inclusion i...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000036

    authors: Lau DK,Andrews MC,Turner N,Azad AA,Davis ID,Cebon JS

    更新日期:2014-04-01 00:00:00

  • Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21.

    abstract::Putative tumour suppressor genes CDKN2A and CDKN2B (on chromosome 9p21) and CDKN2A-interacting cell growth regulatory genes CDK4 and Id-1 have been demonstrated to be involved in the pathogenesis of malignant melanoma (MM). Mutation analysis of these candidate genes was performed in MM families from southern Italy wit...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200312000-00006

    authors: Casula M,Ascierto PA,Cossu A,Sini MC,Tore S,Colombino M,Satta MP,Manca A,Rozzo C,Satriano SM,Castello G,Lissia A,Tanda F,Palmieri G

    更新日期:2003-12-01 00:00:00

  • Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.

    abstract::Resistance to various antineoplastic agents is common in the clinical management of malignant melanoma. The biological mechanisms conferring these different drug-resistant phenotypes are still unclear. To identify potential factors mediating drug resistance to melanoma cells, the mRNA expression profiles of the parent...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/01.cmr.0000215037.23188.58

    authors: Györffy B,Serra V,Materna V,Schäfer R,Dietel M,Schadendorf D,Lage H

    更新日期:2006-04-01 00:00:00

  • Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines.

    abstract::In human melanoma no complete information about the expression of the apoptosis-promoting and apoptosis-inhibiting members of the Bcl-2 family has been available to date. In this study we have investigated by Western blotting the expression pattern of Bcl-2 and its homologues Bax, Bak, Bcl-xL, Bcl-xS, Mcl-1 and Bad in...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199806000-00001

    authors: Selzer E,Schlagbauer-Wadl H,Okamoto I,Pehamberger H,Pötter R,Jansen B

    更新日期:1998-06-01 00:00:00

  • F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.

    abstract::Metabolic imaging with F-18 fluorodeoxy-D-glucose positron emission tomography is one of the most sensitive and non-invasive techniques, and has proved useful in melanoma. We designed, in 2004, at the Institute Gustave Roussy, a prospective study to determine the value of F-18 fluorodeoxy-D-glucose positron emission t...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e32815c10b0

    authors: Maubec E,Lumbroso J,Masson F,Suciu V,Kolb F,Mamelle G,Cavalcanti A,Boitier F,Spatz A,Aupérin A,Leboulleux S,Avril MF

    更新日期:2007-06-01 00:00:00

  • Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens.

    abstract::Accurate staging of patients with primary cutaneous melanoma includes assessment of regional lymph nodes for the presence of micrometastatic disease. Sentinel lymph node biopsy is highly accurate but is an invasive surgical procedure with a 5-10% complication rate, and requires labour-intensive and expensive histologi...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200306000-00006

    authors: Lean CL,Bourne R,Thompson JF,Scolyer RA,Stretch J,Li LX,Russell P,Mountford C

    更新日期:2003-06-01 00:00:00

  • Effect of pEgr-TNFalpha gene radiotherapy on mice melanoma.

    abstract::In the present study, we constructed a pEgr-tumour necrosis factor-alpha (TNFalpha) plasmid and investigated its expression properties in B16 cells on exposure to ionizing irradiation and, furthermore, the effect of gene radiotherapy on a melanoma model. Firstly, the recombinant pEgr-TNFalpha plasmid was constructed a...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200506000-00007

    authors: Wu C,Li X,Tian M

    更新日期:2005-06-01 00:00:00

  • Loss of miR-155 upregulates WEE1 in metastatic melanoma.

    abstract::Significant advances have been made in the treatment of melanoma by targeting key cellular pathways, but additional targets are needed as many patients do not respond or relapse with resistant disease. MicroRNA-155 (MiR-155) has previously been shown to regulate melanoma cell growth and acts as a tumor suppressor. We ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000545

    authors: DiSano JA,Huffnagle I,Gowda R,Spiegelman VS,Robertson GP,Pameijer CR

    更新日期:2019-04-01 00:00:00

  • Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.

    abstract::In order to investigate the effects of in vivo treatment with interferon-alpha (IFN-alpha) on melanoma antigens, a clinical EORTC trial (No. 18852) was accompanied by an immunohistological study. Twenty patients with melanoma metastases of skin and soft tissues, eventually also of the lung, who were treated with syste...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-199306000-00005

    authors: von Stamm U,Bröcker EB,von Depka Prondzinski M,Ruiter DJ,Rümke P,Broding C,Carrel S,Lejeune FJ

    更新日期:1993-06-01 00:00:00

  • Determinants of acute regional toxicity following isolated limb perfusion for melanoma.

    abstract::Hyperthermic isolated limb perfusion (ILP) with melphalan is well established as an effective form of treatment for recurrent melanoma confined to an extremity. High drug concentrations in the limb are readily achieved, without systemic side-effects. However, regional toxicity can lead to considerable morbidity and fu...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-199606000-00010

    authors: Thompson JF,Eksborg S,Kam PC,Ingvar C,Yau DF,Lai DT,Ramzan I

    更新日期:1996-06-01 00:00:00

  • Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

    abstract::This randomized phase II trial was performed to define the activity and toxicity of the combination of dacarbazine (DTIC), carmustine (BCNU), cisplatin (DDP) and tamoxifen (DBDT regimen) versus DTIC alone in patients with metastatic melanoma. Sixty patients with metastatic melanoma were randomly assigned to receive BC...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00008390-200104000-00015

    authors: Chiarion Sileni V,Nortilli R,Aversa SM,Paccagnella A,Medici M,Corti L,Favaretto AG,Cetto GL,Monfardini S

    更新日期:2001-04-01 00:00:00

  • Surgical margins in patients with cutaneous melanoma--assessing the adequacy of excision.

    abstract::Appropriate margins of excision for melanoma have been well defined on the basis of prospective clinical trials. Various factors may result in a discrepancy between the intended clinical margin and the pathologic margin ex vivo, however, making it difficult to determine whether adequate excision margins have been obta...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200512000-00009

    authors: Clausen SP,Brady MS

    更新日期:2005-12-01 00:00:00